Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Clofazimine

A dye of the riminophenazine class, synthesised in 1954 at Trinity College Dublin by a team led by Vincent Barry; intended against tuberculosis, it proved valuable above all in the treatment of leprosy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Being a dye, it builds up in the tissues and in most treated people gives the skin a pigmentation ranging from pink to brownish.

ClofazimineGo to the active ingredient →
ClofazimineActive ingredientClofazimineCat. No. P-C205-001CAS 2030-63-9

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.